FIELD: medicine.
SUBSTANCE: invention relates to methods for preparing glycoconjugates suitable for use in medicine. Proposed are methods for the preparation of glycoconjugates having a molecular weight of 1,000 to 20,000 kDa, containing a bacterial capsular polysaccharide conjugated to a carrier protein, wherein said polysaccharide is covalently attached to said carrier protein, comprising the steps of: a) reacting a bacterial capsular polysaccharide, which is derived from S. pneumoniae and selected from capsular polysaccharides of Pn-serotype 3 (pneumococcal serotype 3), Pn-serotype 10A, Pn-serotype 12F and Pn-serotype 33F, with a stable nitroxyl radical compound and 0.1–10 molar equivalents of the oxidizing agent for selective oxidation of the primary hydroxyl groups to obtain an activated saccharide containing aldehyde groups; b) converting said activated bacterial capsular polysaccharide to an amino group of said carrier protein, selected from tetanus, diphtheria, pertussis toxin, Pseudomonas toxin, E. coli, Staphylococcus, Streptococcus or CRM197, at a ratio of saccharide: carrier/protein (wt/wt) from 0.2 to 4 under reductive amination conditions, wherein, after conjugation, the non-reacted aldehyde groups are converted back to primary alcohols and the glycoconjugate is purified. Also, provided is a glycoconjugate obtained by said methods from a capsular polysaccharide of Pn-serotype 12F, compositions comprising said glycoconjugate, and a method for preventing, treating or alleviating bacterial infections caused by serotype 12F S. pneumoniae, a method for inducing a protective immune response against S. pneumoniae infection by administering said composition to a subject.
EFFECT: provided are new effective methods for the preparation of glycoconjugates, new glycoconjugates and compositions based on them, effective for the treatment of infections caused by Streptococcus pneumoniae.
58 cl, 7 dwg, 5 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF GLYCOCONJUGATION AND COMPOSITION | 2013 |
|
RU2724840C2 |
METHODS OF GLYCOGONJUGATION AND COMPOSITION | 2013 |
|
RU2645071C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED ANTIGENS OF THE CAPSULAR SACCHARIDE, KITS CONTAINING THESE COMPOSITIONS AND USE THEREOF | 2016 |
|
RU2721128C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2687460C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
CONJUGATES OF STREPTOCOCCUS POLYSACCHARIDE GROUP B AND PROTEIN, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATES, AND THEIR USE | 2016 |
|
RU2692923C2 |
Authors
Dates
2018-11-09—Published
2013-12-13—Filed